Brief: Zhongzhi Pharmaceutical Says Lai Ying Feng Appointed As A Chief Executive In Place Of Lai Zhi Tian
25/03/2021 01:25
March 25 (Reuters) - Zhongzhi Pharmaceutical Holdings Ltd
3737.HK :
* LAI YING FENG APPOINTED AS A CHIEF EXECUTIVE IN PLACE OF
LAI ZHI
TIAN
* LAI ZHI TIAN WILL REMAIN AS CHAIRMAN AND AN EXECUTIVE
DIRECTOR
OF CO
Source text for Eikon: ID:nHKSsfCQk
Further company coverage: 3737.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Zhongzhi Pharmaceutical Holdings
See all newsBrief: Zhongzhi Pharmaceutical Expects Over 70% Decrease In 2025 Net Profit
Brief: Zhongzhi Pharmaceutical Expects 90% Decrease In HY Net Profit
Brief: Zhongzhi Pharmaceutical Posts HY Profit Attributable RMB83.4 Million
Brief: Zhongzhi Pharmaceutical Sees Decrease In Net Profit Of 40% For HY
Brief: Zhongzhi Pharmaceutical Declares Final Dividend Of HK3 Cents Per Share